BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...

BIPAVE-001 is a Phase 1/2 trial designed to evaluate the safety, pharmacokinetic, and efficacy of AI-081. The Part A portion ...

Replimune's BLA submission and promising pipeline drugs are set to impact the global melanoma therapeutics market. Read more ...

Adagene Inc. (NASDAQ:ADAG – Get Free Report) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 1,500 shares, a ...

Olympics bronze medallist Bajrang Punia has been handed a 4-year suspension by the National Anti-Doping Agency (NADA) for refusing to provide a urine sample during the selection trials for the ...

Botensilimab (BOT) is a human Fc enhanced CTLA-4 blocking antibody designed to boost both innate and adaptive anti-tumor immune responses. Its novel design leverages mechanisms of action to extend ...

The National Anti-Doping Agency on Tuesday suspended Bajrang Punia for four years for his refusal ... had challenged the charge on July 11 in a written submission following which hearings were held on ...

The FDA has received a biologics license application submission for RP1 plus nivolumab in patients with PD-1 ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal being unveiled Tuesday by the Biden administration. Some 3.4 million ...

What is anti-social behaviour? Anti-social behaviour is a range of behaviours that can cause nuisance and annoyance, or harm and distress to a person. It's a wide range of unacceptable activity. it ...

We will f--- the Arabs.” The episode spread fear in the Jewish community — and revealed long-simmering frustrations over anti-Muslim rhetoric and Islamophobia in the Netherlands. In statements ...

However, there was a significant decrease in mortality from 2015 to 2019, with an APC of -4.39%. Notably, the mortality among men decreased by about 5.84% between 2015 and 2019, while there was no ...